Financial reports
10-Q
2024 Q3
Quarterly report
14 Nov 23
10-Q
2024 Q2
Quarterly report
18 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
ARS
2023 FY
Annual report to shareholders
27 Apr 23
10-K/A
2022 FY
Annual report (amended)
31 Mar 23
10-K
2022 FY
Annual report
27 Mar 23
10-Q
2023 Q3
Quarterly report
14 Nov 22
10-Q
2023 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Amendments to Articles of Incorporation or Bylaws
12 Mar 24
8-K
Entry into a Material Definitive Agreement
14 Feb 24
8-K
Other Events
2 Jan 24
8-K
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
20 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
18 Dec 23
8-K
Departure of Directors or Certain Officers
4 Dec 23
8-K
Departure of Directors or Certain Officers
14 Nov 23
8-K
Departure of Directors or Certain Officers
2 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
16 Oct 23
8-K
Entry into a Material Definitive Agreement
4 Oct 23
Registration and prospectus
15-12G
Securities registration termination
26 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Feb 24
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Feb 24
S-8 POS
Registration of securities for employees (post-effective amendment)
14 Feb 24
POS AM
Prospectus update (post-effective amendment)
14 Feb 24
25-NSE
Exchange delisting
27 Dec 23
424B5
Prospectus supplement for primary offering
5 Oct 23
S-8 POS
Registration of securities for employees (post-effective amendment)
31 Mar 23
S-8
Registration of securities for employees
27 Mar 23
424B5
Prospectus supplement for primary offering
24 May 22
Other
EFFECT
Notice of effectiveness
16 Feb 24
EFFECT
Notice of effectiveness
25 May 22
CORRESP
Correspondence with SEC
20 May 22
UPLOAD
Letter from SEC
20 May 22
EFFECT
Notice of effectiveness
10 Sep 21
CORRESP
Correspondence with SEC
7 Sep 21
CORRESP
Correspondence with SEC
7 Sep 21
UPLOAD
Letter from SEC
30 Aug 21
EFFECT
Notice of effectiveness
23 Apr 21
CERT
Certification of approval for exchange listing
21 Apr 21
Ownership
3
Brandon D Smith
26 Dec 23
4
Change in insider ownership
19 Dec 23
4
Asset Management ULC Brookfield
4 Dec 23
4
Change in insider ownership
4 Dec 23
4
Change in insider ownership
4 Dec 23
SC 13D/A
Oaktree Capital Group, LLC
4 Dec 23
3
Asset Management ULC Brookfield
20 Nov 23
3
Initial statement of insider ownership
20 Nov 23
3
Initial statement of insider ownership
20 Nov 23
SC 13D/A
Oaktree Capital Group, LLC
15 Nov 23